Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening?
about
Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort studyPhysical activity and mammographic density in a cohort of postmenopausal Norwegian women; a cross-sectional studyEffect of organised mammography screening on stage-specific incidence in Norway: population study.Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability.Systematic review about breast cancer incidence in relation to hormone replacement therapy use.Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.Changing patterns of breast cancer incidence and mortality by education level over four decades in Norway, 1971-2009.Balancing the benefits and detriments among women targeted by the Norwegian Breast Cancer Screening Program.Postmenopausal hormone therapy and the risk of breast cancer in Norway.Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women.Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women.Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings.Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution.High incidence and prevalence of systemic lupus erythematosus in Norway.Burden of early, advanced and metastatic breast cancer in The Netherlands.
P2860
Q36023930-17B2D34E-EBAE-4795-B362-9EEAA8079C25Q36589304-E76920F7-4E18-41CE-A16C-0704BA93284FQ36662053-FF8F80BB-496D-43DA-A5B1-663D842027D8Q37003341-8CCEC3B0-0B6A-4527-8ECE-305EBFEBB175Q38126067-E39461D8-AEA6-4591-BF3E-5F1B686D2AA8Q38421948-69D8838B-A78D-4CE7-BA42-A5184CD2019AQ38972327-40F9F576-EF68-46C0-A448-EEAF63DF3C81Q39949342-6D59D4C0-57B2-40F3-8686-BF81378A6F33Q40626144-62DE8EBE-C973-4062-B8E6-0D6778FCDE44Q42457782-671B4D11-03F2-4BD6-996D-83C2D5451C90Q42458258-0A270220-175D-4827-A386-C4C6A088A948Q44594734-2D9120F1-2C29-4859-99BB-8C5BD697CDFEQ46588380-FB0E9226-B926-4905-B4C0-85A6653426EEQ51191137-C2BF45E1-D0A5-4A7F-B255-07F64154EB3EQ55249612-6F15927A-1B91-4D54-971B-AEDD2D7862CD
P2860
Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Breast cancer incidence trends ...... apy or mammographic screening?
@en
Breast cancer incidence trends ...... apy or mammographic screening?
@nl
type
label
Breast cancer incidence trends ...... apy or mammographic screening?
@en
Breast cancer incidence trends ...... apy or mammographic screening?
@nl
prefLabel
Breast cancer incidence trends ...... apy or mammographic screening?
@en
Breast cancer incidence trends ...... apy or mammographic screening?
@nl
P2093
P2860
P356
P1476
Breast cancer incidence trends ...... apy or mammographic screening?
@en
P2093
Sidsel Graff-Iversen
Solveig Hofvind
Solveig Sakshaug
P2860
P304
P356
10.1002/IJC.26280
P50
P577
2011-09-22T00:00:00Z